Skip to content

Lucid Diagnostics LUCD Free cash flow margin

Free cash flow margin at other companies

Castle Biosciences logo
Castle BiosciencesCSTL
1.3%-10.7pp
Guardant Health logo
Guardant HealthGH
-22%-6.7pp
Biodesix, Inc. logo
Biodesix, Inc.BDSX
-26.8%-9.6pp
Insight Molecular Diagnostics Inc. Common Stock logo
Insight Molecular Diagnostics Inc. Common StockIMDX
-1,409.7%-6,023pp
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
-36.9%
Personalis, Inc. logo
Personalis, Inc.PSNL
-131.2%-453pp

Other financials

Income statement

See full
Revenue$1.3M+51.7%
Gross profit-$369.0K+49.0%
Operating income-$12.1M+3.0%
Net income-$13.9M+48.3%
EPS (diluted)-$0.10+60.0%

Balance sheet

See full
Cash & equivalents$27.9M+10.6%
Total debt$1.6M-35.1%
Total equity$4.0M+174%
Total assets$34.1M+3.9%

Cash flow

See full
Operating cash flow-$12.1M+2.9%
CapEx$215.0K+131%
Free cash flow-$12.3M+1.9%

Valuation

See full
Market cap$204.13M+58.5%
Enterprise value$177.85M+78.0%
P/S39.8×+10.2×

Profitability

See full
Gross margin-66.8%
Operating margin-959.6%-133pp
Net margin-876.7%-254pp

Returns & leverage

See full
Return on equity-710.6%
Debt / equity0.4×
Current ratio1.1×+0.3×

Where this comes from

Calculated from Lucid Diagnostics’s reported figures.

Based on trailing twelve months.

The official record: Lucid Diagnostics’s 10-Q, filed May 13, 2025, on SEC EDGAR. View the filing →

Ask your AI about Lucid Diagnostics's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lucid Diagnostics's free cash flow margin?
Lucid Diagnostics (LUCD) reported free cash flow margin of -1,099.6% in Q1 2025.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.